Hydrogen Immunotherapy Makes Cancer Disappear

Hydrogen Immunotherapy Makes Cancer Disappear pdf epub mobi txt 电子书 下载 2026

赤木純兒(Junji Akagi)
圖書標籤:
  • 氫氣療法
  • 癌癥免疫療法
  • 腫瘤治療
  • 氫分子
  • 醫學研究
  • 替代療法
  • 健康
  • 癌癥預防
  • 抗氧化
  • 氫療法
想要找书就要到 灣灣書站
立刻按 ctrl+D收藏本页
你会得到大惊喜!!

圖書描述

  Advice from a Japanese Authority on Immuno-Oncology about how to Enhance Your Immunity Swiftly and Build a Robust Body

  Immune Deficiency, Antineoplastic Drugs, and Radiotherapy Are Unfavorable for Cancer Treatment

  The First Ever Exposition of “Hydrogen Immunotherapy”

  .The Globally First Attempt to Fight Cancer by the Application of Hydrogen, with over 400 Evidence-Based Cases Included
  .Significant Prolongation of the Life Expectancy of Many End-Stage and Recurrent Cancer Patients

  Hydrogen Activates Human Immune Cells!

  The probability of developing cancer has increased significantly with the extension of the average human lifespan. There is an increasing number of literature demonstrating the diverse bioactivities inducible by oxyhydrogen inhalation, including anti-inflammatory, anti-reactive oxygen species (ROS), and antineoplastic effects.

  Evidence has also suggested that hydrogen may be used to mitigate the side effects of traditional chemotherapy, or to inhibit the growth of cancer cells and xenotransplanted tumor. In addition, the application of oxyhydrogen in the treatment of COVID-19 may not only reduce the symptom associated with difficulty breathing, but also exhibit the critical anti-inflammatory effect.

  This book is the first collection of the research and comments made by a Japanese immuno-oncologist on “hydrogen immunotherapy.” Apart from the promising and extensive application in clinical treatment, hydrogen is helpful to prolong the healthy lifespan when used in daily care and health maintenance as well.

  Recommended by
  Dr. He-Chang Kuo, M.D.│professor of the School of Medicine of Chang Gung University
  Dr. Ming-Hsien Huang, M.D.│vice superintendent of E-Da Cancer Hospital
  Dr. Wen-Chang Lin, Ph.D.│chairman of Epoch Energy Technology Co. and Ota Hydrogen Biotech

名人推薦

  “Certainly, research is the foundation of medical advancement. Dr. Akagi has been contributing to the progression of hydrogen medicine through his clinical trials and publications in international journals. Now, he has even written a popular science book to share the collection and analysis of these clinical cases, which is a demonstration of a true spirit of generous giving.”—Dr. He-Chang Kuo│Professor of the School of Medicine of Chang Gung University

  “From the perspective of cancer treatment, Dr. Akagi has presented an abundance of empirical data associated with oxyhydrogen therapy to offer a new treatment position to the world.”—Dr. Ming-Hsien Huang│Vice Superintendent of E-Da Cancer Hospital

  “Hydrogen Immunotherapy makes cancer disappear is one of the bestsellers in Japan. The complete case data and the treatment scheme studied and recorded by Dr. Akagi are surely great contribution to oxyhydrogen applications in the future of medicine. This is a book definitely worth recommending.” —Dr. Wen-Chang Lin, Ph.D.│chairman of Epoch Energy Technology Co. and Ota Hydrogen Biotech
好的,這是一本關於生命科學和新興療法的書籍簡介,完全基於您提供書名中未包含的信息進行創作,力求詳盡且自然。 --- 探索生命前沿:細胞重編程與精準醫療的未來圖景 本書聚焦於當前生物醫學領域最引人注目、最具顛覆性的兩大方嚮:基於基因編輯的細胞重編程技術,以及下一代靶嚮藥物輸送係統如何重新定義癌癥治療的疆界。本書並非對特定療法的詳盡臨床指南,而是一部麵嚮關注科技前沿的專業人士及深度愛好者的深度洞察報告,旨在勾勒齣未來十年內,人類如何利用自身對生命編碼的理解,來重塑疾病治療範式的宏偉藍圖。 第一部分:解碼生命藍圖——重編程技術的革命 本書的開篇深入探討瞭體細胞重編程技術的理論基石及其在生物醫學工程中的實際應用。我們不再僅僅滿足於體外培養,而是緻力於在活體生物體內實現細胞命運的精確調控。 1. 誘導多能乾細胞(iPSCs)的進階應用與倫理考量: 我們詳述瞭從山中因子(Yamanaka Factors)到新型、更高效、更安全的“非病毒載體”重編程方法的演進。重點分析瞭如何剋服當前iPSC技術在臨床轉化中的兩大核心障礙:插入性突變的風險和免疫原性問題。書中詳細介紹瞭“直接重編程”技術(Direct Reprogramming),即不通過多能乾細胞階段,直接將一種成熟細胞(如皮膚成縴維細胞)轉化為另一種所需細胞類型(如神經元或心肌細胞)的最新進展。這為再生醫學提供瞭前所未有的直接通路。 2. 錶觀遺傳調控與基因沉默: 細胞身份的鎖定機製,即錶觀遺傳學,是本書深入探討的另一個核心領域。我們詳細剖析瞭DNA甲基化、組蛋白修飾等分子層麵的開關如何決定細胞的“性格”。書籍引入瞭新興的“錶觀遺傳編輯”工具,例如基於CRISPR-Cas9或dCas9的激活子(CRISPRa)和抑製子(CRISPRi)係統,這些係統能夠精確調控基因的錶達水平,而無需永久性地改變DNA序列本身。這種“軟性”乾預被視為解決復雜、多基因疾病的理想路徑,尤其在神經退行性疾病的研究中展現齣巨大潛力。 3. 細胞工程學的“工廠化”生産: 本書的這一章節側重於將實驗室成果轉化為可大規模、標準化生産的生物製品。我們探討瞭生物反應器設計、自動化過程控製,以及如何建立符閤cGMP(現行藥品生産質量管理規範)標準的細胞工廠,確保從患者自身細胞中提取、修正和擴增的細胞産品具備一緻的高品質和安全性。這對於構建下一代細胞療法的供應鏈至關重要。 第二部分:靶嚮輸送的藝術——納米醫學與藥物遞送革命 在疾病的治療層麵,僅僅擁有高效的藥物分子是不夠的,如何確保藥物在正確的時間、到達正確的地點,同時避免對健康組織造成附帶損害,是現代醫學麵臨的終極挑戰。本書將焦點投嚮瞭納米技術在藥物遞送中的精妙應用。 1. 智能響應性納米載體(Smart Responsive Nanocarriers): 我們係統地梳理瞭從脂質體(Liposomes)到聚閤物膠束(Polymeric Micelles)的進化史。重點介紹的是具有“智能”的載體,它們能夠感應到病竈的微環境特徵——例如pH值的酸性、過氧化氫的高濃度、或特定的酶活性——並在此特定信號下選擇性地釋放有效載荷。這種主動釋放機製極大地提高瞭藥物在腫瘤組織內的滯留時間和濃度,顯著降低瞭全身毒性。 2. 靶嚮配體的設計與優化: 僅僅依靠滲透性來纍積藥物是不夠的,精準的“尋址”係統是關鍵。本書詳細介紹瞭如何利用適體(Aptamers)、單鏈抗體片段(scFv)或特定的肽段作為“導航係統”,錨定在疾病細胞錶麵高錶達的特異性受體上。我們對比瞭主動靶嚮與被動靶嚮(如EPR效應)的優劣,並探討瞭“雙靶嚮”策略如何進一步提高治療指數。 3. 突破血腦屏障(BBB):進入“禁區”的策略: 中樞神經係統(CNS)藥物的開發曆來是生物醫學的難點,主要障礙即是功能強大的血腦屏障。本書專門闢齣章節,分析瞭當前最有前景的幾種穿透BBB的策略,包括利用轉運蛋白介導的內吞作用、破壞緊密連接的局部給藥技術,以及載體本身的錶麵修飾,以模仿內源性分子,欺騙屏障的防禦係統。 第三部分:從數據到洞察——計算生物學與個性化治療 生命科學的爆發式發展産生瞭海量數據,如何從中提取可操作的臨床洞察,是決定未來醫療模式的關鍵。 1. 組學數據整閤與錶型預測: 本書探討瞭多組學數據(基因組學、轉錄組學、蛋白質組學、代謝組學)的深度融閤,並介紹瞭計算模型如何利用這些信息來識彆疾病的生物標誌物和潛在的藥物靶點。我們重點闡述瞭因果推斷模型(Causal Inference Models)在從關聯性數據中提取有效治療乾預措施中的作用,這使得“假設驅動”的研究正嚮“數據驅動”的發現轉變。 2. 臨床試驗的虛擬化與優化: 我們審視瞭“數字孿生”和“器官芯片”(Organ-on-a-Chip)技術在加速藥物開發中的應用。這些高保真度的體外模型能夠模擬復雜的人體生理環境,允許研究人員在安全、可控的環境中篩選候選藥物,並預測其在人體內的藥代動力學行為,從而極大地提高I期和II期臨床試驗的成功率,並減少對動物模型的依賴。 總結: 《探索生命前沿》旨在為讀者提供一個全麵且深入的視角,理解當前生命科學研究是如何從基礎分子機製的解析,逐步邁嚮可工程化、可精準控製的治療策略。本書展示瞭科學界如何以空前的速度和精度,重構我們對生命體、疾病以及治療手段的理解,預示著一個高度個性化、基於生物工程的健康新時代的來臨。

著者信息

作者簡介

Junji Akagi


  Immuno-oncologist
  Specialist and supervising physician of Japan Surgical Society
  Specialist and supervising physician of Japan Society of Gastroenterological Surgery
  Accredited physician for cancer treatment in Japan
  Accredited physician of the Society for Integrative Medicine Japan
  Member of council of the Society for Integrative Medicine Japan and Director of the Kumamoto affiliate
  Director general of International Society for Hydrogen Medicine and Biology

  Dr. Akagi was born in Sasebo City, Nagasaki Prefecture in 1954. After graduating from the College of Liberal Arts of Kyushu University, he attended the School of Medicine of the former Miyazaki Medical University. Intended to become an ideal physician, Dr. Akagi spent day and night studying during his stay at the School of Medicine. In order to gain knowledge and experience, he had even studied in the US at the National Cancer Institute of the National Institutes of Health. While abroad, Dr. Akagi realized the very fact that in every three cancer patients who came to seek treatment, one would eventually die. Although he was disappointed by the situation, he has since striven to rescue terminal cancer patients via every possible measure. Along the way, Dr. Akagi has learned many treatment approaches and chosen to specialize in the field of integrative medicine, where he has met the discipline of hydrogen therapy and established hydrogen immunotherapy as an immunology specialist.

譯者簡介

Wan-Jou Tseng


  Wan-Jou Tseng was a radiographer and sonographer at National University Hospital of Singapore and a postgraduate student of medical ultrasound in Cardiff University. Tseng is a Taiwanese freelance translator specializing in medical and scientific translations.

圖書目錄

Recommendations
I. Can Oxy-hydrogen be Used to Treat COVID-19?  
By Dr. He-Chang Kuo, M.D., Professor of the School of Medicine of Chang Gung University
II. Does Hydrogen Make Cancer Disappear?-My Opinion about Oxy-hydrogen Therapy
By Dr. Ming-Hsien Huang, Vice Superintendent of E-Da Cancer Hospital
III. Persistence Turns what Seemed Unbelievable Yesterday into the Convention of Tomorrow
By Dr. Wen-Chang Lin, Ph.D., Chairman of Epoch Energy Technology Co., and Ota Hydrogen Biotech
 
Foreword

 
Chapter 1  Some Cancer May Disappear, while Some May Not

Rapid- and Slow-Growing Cancers
Cancer Development Is Contributed by Your Lifestyle
95% Cure Rate of Early Cancer
Advanced and Recurrent Cancer Create a Refractory Condition Within Our Bodies
Diet Therapies Are Helpful but Not Enough
 
Chapter 2  Patients Have No Choice
What Are the Three Major Types of Cancer Treatment?
What Is the "Standard of Care"?
The Reason Why the Standard of Care Fails to Cure Terminal Cancer
The Number of Six Hundred Thousand Cancer Refugees Continues to Grow
One Specific Treatment to Save Cancer Refugees
 
Chapter 3  Immune Deficiency Is an Obstacle to the Success of Antineoplastic drugs and Radiotherapy
The Reason Why Current Treatment Options Aren't Working
Even Cancer Experts Have No Idea about the Importance of Immunity
The Cancer-Immunity Cycle Is the Key to Cancer Prevention
To Build a Robust Body with Your Immunity Is of the Utmost Importance
      
Chapter 4  Curing End-Stage Cancer Patients With Hydrogen
How Can Hydrogen Help to Enhance Immunity?
What Exactly Is Hydrogen?
Lift the Immunosuppression to Achieve Successful Treatment Outcome
Hydrogen Increases Opdivo? Response Rate by 40%
Hydrogen Inhalation Causes No Pain and Suffering
Don't Be Afraid to Know Your Remaining Lifespan. Hydrogen Is Your Helper for
  Cancer Elimination
Hydrogen Activates Mitochondria to Boost Your Immunity!
What Are Mitochondria?
Mitochondria Are the Energy Factory of the Human Body
Fasting Increases Mitochondrial Activity
Hydrogen Improves Mitochondrial Function
Mitochondria Quality, Good or Bad
 
Chapter 5  Simple Habits to Boost Your Immunity
7 Ingredients to Improve Mitochondrial Health
Maximize Your Mitochondria with Aerobic Exercise
40℃ Warm Water Baths and High-Quality Sleep Revitalize the Body
Create Your Own Stress-Relief Strategies
Promote Bowel Health with Japanese Fermented Foods
When Your Immunity Remains Low After Trying Everything 
 
Chapter 6  Return to Work Despite "Having Only Two Months to Live"
Sheltering Cancer Patients, Witnessing Their Recoveries
Clinical Cases of Hydrogen Therapy
Case 1: Ovarian Cancer (Stage 4) /Ms. K.H  33 years old
Case 2: Lung Cancer (Stage 4) /Ms. H.S  62 years old
Case 3: Breast Cancer (Stage 4) /Ms. K.M  46 years old
Case 4: Colon Cancer (Recurrence) /Ms. T.K  77 years old
Case 5: Ureteral Cancer (Stage 4) /Mr. K.K  69 years old
Case 6: Breast Cancer (Recurrence) /Ms. T.M  53 years old
Case 7: Prostate Cancer (Recurrence) /Mr. S.T  79 years old
Case 8: Pancreatic Cancer (Stage 4) /Ms. M.M  81 years old
 
Chapter 7  Hydrogen Prolongs Healthy Lifespan by 10 Years
Reaching the Average Life Expectancy in Good Health
Hydrogen Application Prevents Dementia
Alzheimer's Disease Can Be Prevented via the Prevention of Intracerebral Oxidation
Hydrogen Is a Promising Hope for Treatment of Parkinson's Disease
Hydrogen Facilitates Stroke Treatment and Prevention
The Significance of Hydrogen in Myocardial Infarction Treatment and Prevention
Hydrogen Soothes Myalgia and Arthralgia
Hydrogen Works Through the Same Pathway as Sirtuin Genes (Longevity Genes)
An Age-Related Decline in Mitochondrial Function Is Observed in Males Since Age 42
Remove Excess Fat and Maintain a Slim Body
Stress Reduction-Reducing the Origin of Diseases
 
Chapter 8  The Era of Customized Treatment Approaches
"Optimal Medicine" Is the Evolved Version of Integrative Medicine
The Immunity Helps to Raise the Natural Self-Healing Ability of Our Bodies
Simplify Surgical Procedures by Hydrogen Immunotherapy
Hydrogen Reduces Damage Caused by Radiotherapy and Antineoplastic Drugs
Achieve Healthy Longevity by Mitochondria
 
Conclusion
 

圖書序言

  • ISBN:9789571397191
  • 叢書係列:CARE
  • 規格:平裝 / 192頁 / 13.8 x 21 x 1.1 cm / 普通級 / 單色印刷 / 初版
  • 齣版地:颱灣

圖書試讀

Foreword

  “Goodness! The tumor in the lymph nodes was gone! We actually have just started the treatment two weeks ago...” As a specialist in immuno-oncology, I have been treating cancer for over three decades. During these thirty years, various cancer therapies have been developed with the advances in the field of medicine. Although they may be helpful to some patient groups, we are still lacking a single treatment that has been recognized to be effective to most people.
 
  I have been attempting day after day, as a doctor, to mitigate the suffering and to prolong the lives of my patients by all means. In my career, I have never seen any patient experiencing such a speedy recovery in just two weeks. Frankly speaking, when Ms. K.H, 68 years old, came in to our hospital two weeks ago, I even thought to myself, “this lady may not be able to leave this place alive.” That’s exactly how serious her condition was.

  The recurrence of her breast cancer had metastasized to her bones, liver, and cervical lymph nodes, generating a substantial mass on the right side of her jaw. I knew from my previous experience that she was in a critical condition, but I wanted to save her still. This desire prompted me to try on something that was introduced to me not long ago—hydrogen, something that is ubiquitous in nature and present in us all.  

  The swelling of the lymph nodes was gone after the application of hydrogen for two weeks.

  Ms. K.H had experienced a breast cancer recurrence and metastases to cervical lymph nodes, resulting in her swollen jaw. After adding hydrogen to the earlier treatment, the swelling disappeared rapidly within two weeks.
 
  In my usual practice, I use immunotherapy to treat cancer and my treatment protocol basically consists of hyperthermia therapy, low-dose antineoplastic drugs, and Opdivo® (the medicine used in cancer immunotherapy). In Ms. K.H’s case, by the addition of hydrogen, I was deeply surprised to see the remission of her hypertrophic right submandibular gland in just a short period of two weeks.

  Since January 2015, Ms. K.H had continued to take antineoplastic drugs, such as Avastin®+paclitaxel, Avastin®+Abraxane®, and Halaven® for treatment of her recurrent breast cancer, but the value of the tumor marker CA 15-3 had been increasing steadily. Until July 6, 2016, the value rose up to 1630 accompanying her lymph node swelling. This soaring trend is specific to patients with breast cancer. Normally, the value of the tumor marker CA 15-3 should be lower than 31.3. An abnormal level this high may be reflective of the potential presence of multiple metastases to bones and liver. Nevertheless, in two weeks after receiving the combined treatment of immunotherapy and hydrogen, the right submandibular gland hypertrophy had disappeared and Ms. K.H was discharged in good health. On August 3, approximately one month later, the CA 15-3 value had decreased to 1132.

  Before I started treating Ms. K.H, I was introduced by one of my friends to a hydrogen generator, and it was suggested that “hydrogen is useful in cancer treatment.” I was not persuaded initially, but after I realized that hydrogen does not result in potential explosion hazard and is beneficial to the human body in many ways, I couldn’t help thinking, “perhaps this is something worth trying.” Afterwards I witnessed Ms. K.H’s case, which brought me to an idea that “hydrogen may become one of the great promises for cancer treatment in the future.”

  Consequently, I have begun to perform ongoing research and established hydrogen immunotherapy at last. This is the first attempt in the world to treat cancer with hydrogen, and we have successfully cured more than 400 patients to significantly prolong the remaining lifespan of many end-stage or recurrent cancer patients. In addition, I published my article in the British academic journal, Oncology Reports, and received considerable attention globally. In December 2018, I gave a speech about “the advent of the application of immunotherapy for advanced cancer—combined immunotherapy” at the 6th World Integrative Medicine Congress held in Shanghai, China (where 2,500 doctors participated). In May 2019, a group of 40 doctors from China attended the event hosted by the Society for Integrative Medicine Japan at Aichi Medical University. Also, in mid-June of the same year, I departed for Guangzhou, China to attend a relevant event.

  Written in the above-mentioned background, this book documents the details of the unprecedented hydrogen immunotherapy in the world. While the standard of care, including antineoplastic drugs and radiotherapy, has failed to cure cancer and becomes a hopeless option by physicians, I wish to inform the distressed or exhausted patients and families of a potentially promising treatment approach, the mechanism and case reports of which are covered in this book. I think, even if you have been told, “there is nothing we can do for you now,” or asked, “are you willing to consider palliative care?” it would be truly a blessing to learn that there is still hope of survival.

用户评价

评分

這本書的封麵設計真是讓人眼前一亮,那種深邃的藍色調配上簡潔的字體,營造齣一種既專業又帶點神秘的氛圍。從書名來看,主題似乎非常前沿,讓人不禁好奇作者是如何將這些看似不相關的概念——氫氣、免疫療法與癌癥的消失——編織在一起的。我期待它能以一種深入淺齣的方式,將復雜的生物學原理闡述得清晰易懂,而不是堆砌一堆拗口的術語。如果作者能用生活化的例子來比喻那些高深的科學機製,那就更好瞭,畢竟對於我們這些非專業人士來說,理解背後的邏輯比記住一堆名詞重要得多。我特彆關注它在理論基礎上的紮實力度,畢竟在醫學領域,任何“奇跡”的背後都需要堅實的科學支撐。希望這本書不僅是提供瞭一種新的希望,更能給我們帶來對生命科學新的認知視角。那種兼具嚴謹性和可讀性的平衡感,是衡量一本優秀科普讀物的重要標準,期待它能在這方麵交齣令人滿意的答捲。

评分

坦白說,現在市麵上關於“抗癌秘籍”的書籍多如牛毛,很多都是捕風捉影、缺乏實證支撐的“心靈雞湯”。因此,這本書如果能做到信息來源的透明化和引用的權威性,將極大地提升其可信度。我非常在意作者在描述具體機製時,是否有充分引用頂尖期刊的研究數據作為佐證。一個嚴謹的作者,應該會誠實地指齣目前研究的局限性和未來可能遇到的挑戰,而不是一味地誇大療效。如果能看到詳盡的附錄、參考文獻列錶,並且這些引用是來自國際公認的權威機構,那麼即使內容再晦澀,我也願意花時間去鑽研。畢竟,在與重病抗爭這件事上,可靠性永遠是排在第一位的要素,任何含糊其辭都是對讀者不負責任的錶現。

评分

這本書的裝幀質感摸起來相當不錯,紙張的厚度適中,油墨印刷的清晰度也達到瞭齣版品的上乘水準,這點對於需要反復翻閱的工具書來說非常加分。不過,光有好的外錶是不夠的,我更關心的是其內容結構是否閤理。一個好的敘事結構能引導讀者自然而然地進入作者設定的知識體係。我希望作者能夠精心設計章節的遞進關係,也許可以從宏觀的癌癥病理談起,逐步深入到微觀的分子層麵,最後再迴到應用和展望。這樣的層次感能讓讀者的知識吸收過程更加順暢,避免瞭信息轟炸帶來的疲憊感。如果章節之間的過渡處理得巧妙,用一些引人深思的小標題來連接,那就更棒瞭。總而言之,閱讀體驗不僅關乎內容,也關乎閱讀的“旅程”設計,希望這本書能提供一段順暢而引人入勝的旅程。

评分

這本書的定價和目標讀者群設定,也間接反映瞭它想達到的深度。如果它定位在麵嚮普通大眾的普及讀物,那麼語言的親切度和實用性就成瞭關鍵;但如果它的目標讀者是醫學界的同行或相關研究人員,那麼詳盡的實驗數據和嚴密的邏輯推導就不可或缺瞭。我個人更偏愛那種“雙層結構”的書籍:一方麵,它能提供一個給大眾理解的科普框架;另一方麵,在附錄或特定章節中,又能為專業人士提供足夠的數據支撐和方法論探討。這樣的設計,使得這本書能服務於更廣泛的讀者群體,讓專業人士能深入挖掘,而初學者也能有所收獲。希望作者在內容分級上做得足夠細緻,讓不同背景的讀者都能找到屬於自己的那份收獲,而不是讓新手望而卻步,讓專傢覺得淺嘗輒止。

评分

從一個資深“書蟲”的角度來看,一本真正的好書,它的價值往往體現在它如何挑戰既有的認知框架。我對這本書的期待,不僅僅是學習到新的治療方法,而是它能否提供一個全新的、甚至是顛覆性的視角來看待人體的自我修復機製。如果作者能夠以一種哲學思辨的口吻,探討人類在對抗疾病過程中,與自然界(比如氫氣這種基礎元素)的互動關係,那就非常深刻瞭。我希望它能跳脫齣純粹的醫學報告範疇,融入一些對生命本質的思考。這種帶有思辨色彩的論述,往往能讓人在讀完之後,對自己的健康乃至生命有更深層次的體悟,而不是僅僅停留在“知識點”的層麵。那種讀完後能讓人靜坐沉思許久的書,纔是真正的佳作。

相关图书

本站所有內容均為互聯網搜尋引擎提供的公開搜索信息,本站不存儲任何數據與內容,任何內容與數據均與本站無關,如有需要請聯繫相關搜索引擎包括但不限於百度google,bing,sogou

© 2026 twbook.tinynews.org All Rights Reserved. 灣灣書站 版權所有